PMD44 Economic Evaluation of the UGT1A1 Pharmacogenetic Test to inform Dose Selection of Irinotecan-Based Chemotherapy
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.116
https://www.valueinhealthjournal.com/article/S1098-3015(11)01678-0/fulltext
Title :
PMD44 Economic Evaluation of the UGT1A1 Pharmacogenetic Test to inform Dose Selection of Irinotecan-Based Chemotherapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01678-0&doi=10.1016/j.jval.2011.08.116
First page :
A252
Section Title :
Medical Device/Diagnostics
Open access? :
No
Section Order :
102